Indivior Pharmaceuticals, Inc. INDV Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's allowance for doubtful accounts receivable (current)?
- Indivior Pharmaceuticals, Inc. (INDV) reported allowance for doubtful accounts receivable (current) of $3M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's allowance for doubtful accounts receivable (current) changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's allowance for doubtful accounts receivable (current) increased by 50.0% year-over-year, from $2M to $3M.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.